Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Folic acid fortification

This article was originally published in The Tan Sheet

Executive Summary

Folic acid fortification: Delivery of 200 mcg daily is "effective against neural-tube defects and safer for the general population" than 400 mcg daily, Sean Daly, Coombe Women's Hospital, Dublin, et al., say in a study published in the Dec. 6 issue of The Lancet. In the study, 121 women were randomly assigned placebo or 100, 200 or 400 mcg daily folic acid for six months to determine the intake necessary to increase blood folate to a level shown to prevent most neural tube defects. The researchers conclude: "A fortification programme that delivered 400 mcg folic acid daily to women would protect against NTD, but at the expense of unnecessarily high exposure for many people." The National Academy of Sciences' recommended daily allowance is 400 mcg for pregnant women, 180 mcg for other women and 200 mcg for men...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel